Kerry Group Targets 20%-21% Margins as Biotech Fuels Taste and Nutrition Growth

Key Points

• Kerry Group is targeting a 20%–21% EBITDA margin by 2030, building on 320 basis points of margin expansion since 2021 and aiming for continued high-single-digit-plus EPS growth.
• The company plans to increase R&D spending to 5%–6% of revenue while expanding biotechnology applications in sugar and sodium reduction, protein masking, clean-label preservation and functional nutrition.
• Kerry sees a specialty ingredients market growing from about €87 billion to more than €100 billion, driven by demand for healthier, affordable and differentiated products and by faster innovation cycles among retailers, restaurants and challenger brands.

Kerry Group LON: KYGA said it is positioning its technology portfolio, biotechnology capabilities and customer-focused application expertise to capture growing food and beverage innovation and renovation opportunities, particularly as consumers demand healthier, more affordable and differentiated products.

Speaking at the company’s Technology and Innovation Center in Beloit, Wisconsin, Edmond said Kerry has completed its transformation into a pure-play business-to-business taste and nutrition company. He said the company is now focused on executing its strategy and financial plan through volume growth, margin expansion and high-single-digit-plus earnings-per-share growth.

“We operate in a highly dynamic market,” Edmond said, citing health and wellness trends, regulation, GLP-1, digital consumer behavior, inflation and supply-chain disruptions as forces prompting food and beverage producers to reformulate and improve products.

Financial and portfolio progress

Edmond said Kerry has delivered 3.8% revenue volume growth over the past four years and more than 300 basis points of market outperformance. The company expanded EBITDA margin by 320 basis points since 2021 and is targeting an EBITDA margin of 20% to 21% by 2030.

He also said Kerry has achieved high-single-digit constant-currency EPS growth in eight of the last 10 years, including in 2024 and 2025, and is on track for similar growth in 2026.

The company’s portfolio development has included investments in biotechnology, enzyme manufacturing, pre-, pro- and postbiotics, protein masking, sugar and salt reduction, natural food protection and preservation systems. Kerry also expanded its geographic footprint in Asia, Africa, the Middle East and Latin America.

Edmond said more than half of Kerry’s business is in the Americas, while its emerging-markets business totals €2.2 billion. He said the company sees growth opportunities across global, regional and local customers, as well as in retail and foodservice channels.

Kerry estimates its addressable value-added specialty ingredients market at about €87 billion and expects it to exceed €100 billion over the next five to 10 years, driven primarily by product renovation.

Biotechnology investment and product development

Chief Science and Technology Officer Albert McQuaid said Kerry has invested more than €3 billion in its research, development and application ecosystem over the past decade. The company currently invests €315 million annually in research, development and applications, supporting more than 1,300 scientists.

McQuaid said Kerry intends to increase research and development spending from roughly 5% of revenue today to between 5% and 6% of revenue. The investment is intended to connect science, technology and product application work across geographies, channels and food and beverage categories.

He said 40% of Kerry’s taste portfolio is delivered through biotechnology, supported by biofermentation and biotransformation capabilities. Kerry is using those capabilities in sodium reduction, sugar reduction, protein masking, clean-label preservation and fermentation-based taste systems.

McQuaid identified five future technology areas for the company, each with a potential opportunity of more than €50 million:

• Modulation technologies for advanced nutrition.
• Biotechnology-based replacement of ingredients while maintaining safety, quality and shelf life.
• Solutions addressing raw-material and resource scarcity.
• Data- and science-led preservation aimed at reducing food waste.
• Nutrition solutions designed to play a more proactive role in human health.

He also said Kerry plans to use digital tools and artificial intelligence to capture commercial, formulation and analytical knowledge, allowing scientists to spend more time solving customer challenges.

North American market trends

Elizabeth Horvath, Kerry’s vice president of marketing for North America, described a fast-moving market shaped by social media, emerging brands and changing consumer spending behavior. She said 17,000 products across 4,400 brands have launched in the region over the past two years.

Horvath said Circana’s top 200 new retail product launches generated $6.2 billion in first-year sales. She also said one-third of U.S. consumers are using AI to discover new products, shortening the path between product inspiration and purchase.

While 79% of consumers are trading down, she said 40% of those consumers are also splurging in other categories. That means consumers may purchase lower-cost staples while paying a premium for products such as functional beverages.

Horvath highlighted refreshers, protein-enriched products, pickle-flavored products and cottage cheese-based foods as examples of trends reshaping product development. She said the broader takeaway is that consumers increasingly want health, indulgence, novelty and value in the same product experience.

Customer complexity and speed

John Cahalane, president and CEO of Kerry North America, said Kerry’s North American business now exceeds €3 billion. He said customers across retail, foodservice and consumer packaged goods are contending with rising expectations, shorter innovation cycles and greater formulation complexity.

Cahalane said retailer brands are increasingly competing directly with national consumer packaged goods brands, with 80% of consumers regularly purchasing retailer brands. Retailers are investing in quality, nutrition, innovation and differentiation, he said.

He also pointed to faster restaurant expansion and the growth of smaller challenger brands, which he said have taken 1.5 percentage points of market share from consumer packaged goods companies over the past three years.

“Solutions at speed wins,” Cahalane said, arguing that Kerry’s integrated technology, application and customer-partnership model is designed to help customers respond to those market changes.

About Kerry Group (LON:KYGA)

Kerry Group plc, together with its subsidiaries, provides taste and nutrition solutions. The company operates in two segments, Taste & Nutrition, and Dairy Ireland. The Taste & Nutrition segment offers taste and nutrition solutions for the food, beverage, and pharmaceutical markets. The Dairy Ireland segment provides value-add dairy ingredients and consumer products, including functional proteins and nutritional bases. It operates in Ireland, rest of Europe, the Americas, the Asia Pacific, the Middle East, and Africa.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.